Literature DB >> 9045941

Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat.

R Hasegawa1, I Yoshimura, K Imaida, N Ito, T Shirai.   

Abstract

The effects of simultaneous treatment with 5 or 10 heterocyclic amines at low dose levels on hepatocarcinogenesis in rats were investigated using a medium-term liver bioassay protocol based on the two-stage carcinogenesis hypothesis with diethylnitrosamine initiation (200 mg/kg, i.p.). Five carcinogenic heterocyclic amines in experiment 1 (Trp-P-1, Glu-P-2, IQ, MeIQ, MeIQx) and experiment 2 (Trp-P-2, Glu-P-1, MeAalphaC, AalphaC, PhIP) were administered together or individually in the diet at levels of 1/1, 1/5, or 1/25 carcinogenic doses, and all 10 chemicals were given at 1/10 or 1/100 levels in experiment 3. Induction of preneoplastic glutathione S-transferase placental form (GST-P)-positive foci in the liver was generally increased in the combination groups over the sums of the 5 or 10 individual effects. Thus, based on the heteroadditive concept, synergism was observed for each combination, being most obvious in the group given all 10 chemicals at the 1/10 dose levels. However, the values for the combined groups were generally close to the averages of the 5 or 10 data gained for the heterocyclic amines alone at the corresponding higher doses, indicating the possibility of isoadditivity. Based on these findings, we propose here a new statistical method for analysis of combined effects of multiple chemicals, and, using this, we demonstrated (true) synergism with some heterocyclic amine combinations. The importance of dose-response curves for evaluation of combination effects is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9045941      PMCID: PMC5921017          DOI: 10.1111/j.1349-7006.1996.tb03122.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

Review 2.  Epidemiology and the prevention of cancer: some recent developments.

Authors:  R Doll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 3.  Risk assessment of chemical mixtures: biologic and toxicologic issues.

Authors:  M M Mumtaz; I G Sipes; H J Clewell; R S Yang
Journal:  Fundam Appl Toxicol       Date:  1993-10

4.  Heterocyclic amines in cooked foods: possible human carcinogens.

Authors:  J H Weisburger
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

Review 5.  Criteria for analyzing interactions between biologically active agents.

Authors:  M C Berenbaum
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

Review 6.  Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates.

Authors:  R Kato
Journal:  Crit Rev Toxicol       Date:  1986       Impact factor: 5.635

7.  A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Authors:  N Ito; R Hasegawa; M Sano; S Tamano; H Esumi; S Takayama; T Sugimura
Journal:  Carcinogenesis       Date:  1991-08       Impact factor: 4.944

Review 8.  Multistep carcinogenesis: a 1992 perspective.

Authors:  T Sugimura
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

9.  Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  H Esumi; H Ohgaki; E Kohzen; S Takayama; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1989-12

10.  Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses.

Authors:  R Hasegawa; T Shirai; K Hakoi; K Takaba; S Iwasaki; T Hoshiya; N Ito; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  1 in total

1.  Metabolites of the carcinogen 2-amino-alpha-carboline formed in male Sprague-Dawley rats in vivo and in rat hepatocyte and human HepG2 cell incubates.

Authors:  Zhi-Xin Yuan; Gautam Jha; Michael A McGregor; Roberta S King
Journal:  Chem Res Toxicol       Date:  2007-02-10       Impact factor: 3.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.